These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4616800)
1. Elution of cell-bound anti-prostatic epithelial antibodies after multiple cryotherapy of carcinoma of the prostate. Ablin RJ; Gonder MJ; Soanes WA Cryobiology; 1974 Jun; 11(3):218-21. PubMed ID: 4616800 [No Abstract] [Full Text] [Related]
2. Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate. Ablin RJ; Soanes WA; Gonder MJ Urology; 1973 Sep; 2(3):276-9. PubMed ID: 4127037 [No Abstract] [Full Text] [Related]
3. Immunohistologic studies of carcinoma of the prostate. 3. Elution of interepithelial antibodies from carcinomatous human prostatic tissue following cryoprostatectomy. Ablin RJ; Gonder MJ; Soanes WA Oncology; 1974; 29(4):329-34. PubMed ID: 4601846 [No Abstract] [Full Text] [Related]
4. Regression of prostatic cancer following sequential cryotherapy to the prostate. Gursel E; Roberts M; Veenema RJ J Urol; 1972 Dec; 108(6):928-32. PubMed ID: 4117196 [No Abstract] [Full Text] [Related]
13. [Cryotherapy in 141 cases of carcinoma of the prostate reviewed after 5 years (author's transl)]. Sesia G; De Luca G; Chiaudano C; Cauda F J Urol (Paris); 1982; 88(3):155-8. PubMed ID: 7097031 [TBL] [Abstract][Full Text] [Related]
14. Sequential cryotherapy for prostatic carcinoma: does it palliate the bone pain? Horan AH Conn Med; 1975 Feb; 39(2):81-3. PubMed ID: 45896 [No Abstract] [Full Text] [Related]
15. B.C.G. immunotherapy in carcinoma of prostate. Guinan P; Bush IM; John T; Sadoughi N; Ablin RJ Lancet; 1973 Aug; 2(7826):443-4. PubMed ID: 4124919 [No Abstract] [Full Text] [Related]
17. The new aspects of immunotherapy in prostate cancer. Ghanei M; Shohrati M; Saburi A Cancer Immunol Immunother; 2012 Dec; 61(12):2375-6. PubMed ID: 22736256 [No Abstract] [Full Text] [Related]
18. Clinical and experimental considerations of the immunologic response to prostatic and other accessory glands tissues of reproduction. Ablin RJ; Soanes WA; Gonder MJ Urol Int; 1970; 25(5):511-39. PubMed ID: 4111980 [No Abstract] [Full Text] [Related]
19. Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma. Brandes A; Weinmann M; Reichmann U; Becker G; Gärtner HV; Bamberg M Acta Oncol; 2001; 40(7):879-81. PubMed ID: 11859991 [No Abstract] [Full Text] [Related]
20. Adenosquamous carcinoma of the prostate. Moyana TN Am J Surg Pathol; 1987 May; 11(5):403-7. PubMed ID: 3555133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]